S
Description
Substipharm is a private French healthcare group operating in over 100 countries with direct presence in Europe and Southeast Asia. The company develops and commercializes a portfolio of over 90 different pharmaceutical molecules with a focus on niche and well-differentiated established products. Recently acquired iconic brands Aspégic and Kardégic/Cardirene from major pharmaceutical companies.